Di Jiang

Q: What is Di Jiang email address?

Email Di Jiang at di.jiang@novartis.com. This email is the most updated Di Jiang email found in 2026.

Q: How to contact Di Jiang?

To contact Di Jiang send an email to di.jiang@novartis.com. (updated on November 04, 2024)

Principal Scientist at Novartis Institutes for BioMedical Research (NIBR) | Greater Boston

About Di Jiang

Di Jiang is a highly accomplished Principal Scientist at the Novartis Institutes for BioMedical Research (NIBR), where he leverages over 15 years of extensive experience in immunology and inflammation research to drive innovative drug discovery initiatives. With a robust background in cell biology, Di specializes in target identification and validation, playing a pivotal role in advancing therapeutic candidates through the drug development pipeline. His expertise encompasses the design and execution of cell-based assays, high-throughput screening (HTS), and assay development, enabling the identification of novel drug targets that address unmet medical needs.

At NIBR, Di is currently leading key projects that focus on elucidating the mechanisms of action of potential therapeutics in inflammatory diseases. His hands-on research experience is complemented by a deep understanding of advanced techniques such as Western blotting, cell culture, and sequencing, which he employs to generate high-quality data that informs decision-making in project development. Di's passion for collaboration is evident in his work with cross-functional teams, where he fosters an environment of open communication and knowledge sharing to accelerate research outcomes.

In addition to his technical skills, Di is an adept storyteller, translating complex scientific concepts into compelling narratives that resonate with both scientific and non-scientific audiences. His ability to articulate research findings through manuscript and report writing not only enhances the visibility of his projects but also contributes to the broader scientific community. As Di continues to push the boundaries of immunology research at NIBR, he remains committed to driving impactful discoveries that can transform patient care.

Di Jiang Work